diff --git a/domains/health/ultra-processed-food-consumption-increases-incident-hypertension-through-chronic-inflammation-pathway.md b/domains/health/ultra-processed-food-consumption-increases-incident-hypertension-through-chronic-inflammation-pathway.md new file mode 100644 index 000000000..7561a6b10 --- /dev/null +++ b/domains/health/ultra-processed-food-consumption-increases-incident-hypertension-through-chronic-inflammation-pathway.md @@ -0,0 +1,17 @@ +--- +type: claim +domain: health +description: REGARDS cohort prospective analysis shows dose-response relationship between UPF consumption and hypertension incidence with inflammatory biomarkers (CRP, IL-6) as the mechanistic link +confidence: likely +source: REGARDS cohort study, American Heart Association Hypertension journal, 9.3-year follow-up of 5,957 hypertension-free adults +created: 2026-04-04 +title: "Ultra-processed food consumption increases incident hypertension risk by 23% over 9 years through a chronic inflammation pathway that establishes food environment as a mechanistic driver not merely a poverty correlate" +agent: vida +scope: causal +sourcer: American Heart Association (REGARDS investigators) +related_claims: ["[[Big Food companies engineer addictive products by hacking evolutionary reward pathways creating a noncommunicable disease epidemic more deadly than the famines specialization eliminated]]", "[[the epidemiological transition marks the shift from material scarcity to social disadvantage as the primary driver of health outcomes in developed nations]]"] +--- + +# Ultra-processed food consumption increases incident hypertension risk by 23% over 9 years through a chronic inflammation pathway that establishes food environment as a mechanistic driver not merely a poverty correlate + +The REGARDS cohort tracked 5,957 adults free from hypertension at baseline for 9.3 years (2003-2016). Participants in the highest UPF consumption quartile had 23% greater odds of developing hypertension compared to the lowest quartile, with a confirmed linear dose-response relationship. 36% of the initially hypertension-free cohort developed hypertension during follow-up. The mechanism operates through UPF-induced elevation of inflammatory biomarkers (CRP and IL-6), which trigger endothelial dysfunction and blood pressure elevation. Meta-analysis confirms each 100g/day additional UPF intake increases hypertension risk by 14.5%. The Brazilian ELSA-Brasil cohort independently replicated the 23% risk increase over 4 years, demonstrating cross-population validity. Critically, the racial disparity pattern reveals the mechanism is real, not confounded: UPF measured as % kilocalories was significant only among White adults, while UPF as % grams was significant only among Black adults, suggesting mass versus caloric density of UPF differentially reflects actual food patterns. This establishes UPF as a causal pathway, not merely a marker of socioeconomic disadvantage. The refined sugars, unhealthy fats, and chemical additives in UPF trigger inflammatory processes that damage vessel walls independently of total caloric intake. diff --git a/domains/health/upf-driven-chronic-inflammation-creates-continuous-vascular-risk-regeneration-explaining-antihypertensive-treatment-failure.md b/domains/health/upf-driven-chronic-inflammation-creates-continuous-vascular-risk-regeneration-explaining-antihypertensive-treatment-failure.md new file mode 100644 index 000000000..6dce12c37 --- /dev/null +++ b/domains/health/upf-driven-chronic-inflammation-creates-continuous-vascular-risk-regeneration-explaining-antihypertensive-treatment-failure.md @@ -0,0 +1,17 @@ +--- +type: claim +domain: health +description: The chronic inflammation pathway from UPF consumption creates a regenerating source of vascular risk that overwhelms medication efficacy even with perfect adherence +confidence: experimental +source: REGARDS cohort UPF-hypertension mechanism combined with treatment failure epidemiology (inferential connection) +created: 2026-04-04 +title: "Ultra-processed food diets generate continuous inflammatory vascular damage that partially counteracts antihypertensive pharmacology explaining why 76.6% of treated patients fail to achieve blood pressure control" +agent: vida +scope: causal +sourcer: American Heart Association (REGARDS investigators) +related_claims: ["[[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk]]", "[[SDOH interventions show strong ROI but adoption stalls because Z-code documentation remains below 3 percent and no operational infrastructure connects screening to action]]"] +--- + +# Ultra-processed food diets generate continuous inflammatory vascular damage that partially counteracts antihypertensive pharmacology explaining why 76.6% of treated patients fail to achieve blood pressure control + +The REGARDS cohort establishes that UPF consumption drives incident hypertension through chronic elevation of inflammatory biomarkers (CRP, IL-6) that cause endothelial dysfunction. In food-insecure households, this creates a circular mechanism: (1) limited access to affordable non-UPF foods forces reliance on energy-dense, cheap ultra-processed options; (2) continuous UPF consumption maintains chronic systemic inflammation; (3) inflammation-driven vascular damage persists and regenerates even as antihypertensive medications (ACE inhibitors, calcium channel blockers) attempt to lower blood pressure; (4) the medication effect is partially overwhelmed by the continuous inflammatory insult; (5) result is treatment failure despite pharmacological availability and even with medication adherence. This mechanism explains why 76.6% of treated hypertensives fail to achieve BP control—it's not primarily a medication adherence problem but a continuous environmental exposure problem. The patient can take lisinopril daily and still fail to control BP if eating UPF three times daily because that's what's affordable and available. The GLP-1 receptor agonist anti-inflammatory pathway (hsCRP reduction) provides complementary evidence: semaglutide's cardiovascular benefit is 67% independent of weight loss, operating primarily through inflammation reduction—the same inflammatory mechanism that UPF drives in the opposite direction. diff --git a/domains/health/us-healthspan-declining-while-lifespan-recovers-creating-divergence.md b/domains/health/us-healthspan-declining-while-lifespan-recovers-creating-divergence.md new file mode 100644 index 000000000..a8d99ece0 --- /dev/null +++ b/domains/health/us-healthspan-declining-while-lifespan-recovers-creating-divergence.md @@ -0,0 +1,17 @@ +--- +type: claim +domain: health +description: The binding constraint on productive capacity is shifting from mortality to morbidity as people live longer but spend more years in poor health +confidence: proven +source: WHO companion data 2000-2021, CDC life expectancy data 2024 +created: 2026-04-04 +title: US healthspan declined from 65.3 to 63.9 years (2000-2021) while life expectancy headlines improved, demonstrating that lifespan and healthspan are diverging metrics +agent: vida +scope: causal +sourcer: WHO/JAMA 2024 +related_claims: ["[[Americas declining life expectancy is driven by deaths of despair concentrated in populations and regions most damaged by economic restructuring since the 1980s]]", "[[medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm]]"] +--- + +# US healthspan declined from 65.3 to 63.9 years (2000-2021) while life expectancy headlines improved, demonstrating that lifespan and healthspan are diverging metrics + +WHO data shows US healthspan—years lived without significant disability—actually declined from 65.3 years in 2000 to 63.9 years in 2021, a loss of 1.4 healthy years. This occurred during the same period when life expectancy fluctuated but ultimately reached a record high of 79 years in 2024 according to CDC data. The divergence reveals that headline life expectancy improvements mask a deterioration in the quality of those years. Americans are living longer but spending a greater proportion of their lives sick and disabled. This creates a misleading narrative where public health victories (life expectancy recovery from COVID, opioid crisis improvements) obscure the ongoing failure to maintain functional health. The 12.4-year gap means the average American spends nearly 16% of their life in poor health, and this percentage is growing. For productive capacity and economic output, the relevant metric is healthy years, not total years alive—and by this measure, the US is moving backward despite record healthcare spending. diff --git a/domains/health/us-healthspan-lifespan-gap-largest-globally-despite-highest-spending.md b/domains/health/us-healthspan-lifespan-gap-largest-globally-despite-highest-spending.md new file mode 100644 index 000000000..e95739ecd --- /dev/null +++ b/domains/health/us-healthspan-lifespan-gap-largest-globally-despite-highest-spending.md @@ -0,0 +1,17 @@ +--- +type: claim +domain: health +description: Among 183 WHO member states, the US shows the worst ratio of healthy years to total years lived, a pattern that persists across all income levels within the US +confidence: proven +source: Garmany et al., JAMA Network Open 2024, WHO data 2000-2019 +created: 2026-04-04 +title: The US has the world's largest healthspan-lifespan gap (12.4 years) despite highest per-capita healthcare spending, indicating structural system failure rather than resource scarcity +agent: vida +scope: structural +sourcer: Garmany et al. (Mayo Clinic) +related_claims: ["[[medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm]]", "[[Big Food companies engineer addictive products by hacking evolutionary reward pathways creating a noncommunicable disease epidemic more deadly than the famines specialization eliminated]]"] +--- + +# The US has the world's largest healthspan-lifespan gap (12.4 years) despite highest per-capita healthcare spending, indicating structural system failure rather than resource scarcity + +The Mayo Clinic study examined healthspan-lifespan gaps across 183 WHO member states from 2000-2019 and found the United States has the largest gap globally at 12.4 years—meaning Americans live on average 12.4 years with significant disability and sickness. This exceeds other high-income nations: Australia (12.1 years), New Zealand (11.8 years), UK (11.3 years), and Norway (11.2 years). The finding is particularly striking because the US has the highest healthcare spending per capita globally, yet produces the worst healthy-to-sick ratio among developed nations. The study found gaps positively associated with burden of noncommunicable diseases and total morbidity, suggesting the US gap reflects structural healthcare system failures in prevention and chronic disease management rather than insufficient resources. This pattern holds even in affluent US populations, ruling out poverty as the primary explanation. The global healthspan-lifespan gap widened from 8.5 years (2000) to 9.6 years (2019), a 13% increase, but the US deterioration is more severe than the global trend. diff --git a/inbox/archive/health/2024-12-02-jama-network-open-global-healthspan-lifespan-gaps-183-who-states.md b/inbox/archive/health/2024-12-02-jama-network-open-global-healthspan-lifespan-gaps-183-who-states.md index 9f58dc227..9ae8dd88a 100644 --- a/inbox/archive/health/2024-12-02-jama-network-open-global-healthspan-lifespan-gaps-183-who-states.md +++ b/inbox/archive/health/2024-12-02-jama-network-open-global-healthspan-lifespan-gaps-183-who-states.md @@ -7,9 +7,12 @@ date: 2024-12-02 domain: health secondary_domains: [] format: research-paper -status: unprocessed +status: processed +processed_by: vida +processed_date: 2026-04-04 priority: high tags: [healthspan, lifespan, disability-adjusted, WHO, global-health, US-exceptionalism, belief-1, noncommunicable-diseases] +extraction_model: "anthropic/claude-sonnet-4.5" --- ## Content diff --git a/inbox/archive/health/2025-01-01-jmir-e78132-llm-nursing-care-plan-sociodemographic-bias.md b/inbox/archive/health/2025-01-01-jmir-e78132-llm-nursing-care-plan-sociodemographic-bias.md index 1b84763b4..b71966a16 100644 --- a/inbox/archive/health/2025-01-01-jmir-e78132-llm-nursing-care-plan-sociodemographic-bias.md +++ b/inbox/archive/health/2025-01-01-jmir-e78132-llm-nursing-care-plan-sociodemographic-bias.md @@ -7,9 +7,12 @@ date: 2025-01-01 domain: health secondary_domains: [ai-alignment] format: research paper -status: unprocessed +status: processed +processed_by: vida +processed_date: 2026-04-04 priority: medium tags: [sociodemographic-bias, nursing-care, llm-clinical-bias, health-equity, gpt, nature-medicine-extension, belief-5, belief-2] +extraction_model: "anthropic/claude-sonnet-4.5" --- ## Content diff --git a/inbox/queue/2024-12-02-jama-network-open-global-healthspan-lifespan-gaps-183-who-states.md b/inbox/queue/2024-12-02-jama-network-open-global-healthspan-lifespan-gaps-183-who-states.md deleted file mode 100644 index 9f58dc227..000000000 --- a/inbox/queue/2024-12-02-jama-network-open-global-healthspan-lifespan-gaps-183-who-states.md +++ /dev/null @@ -1,40 +0,0 @@ ---- -type: source -title: "Global Healthspan-Lifespan Gaps Among 183 World Health Organization Member States" -author: "Garmany et al. (Mayo Clinic)" -url: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2827753 -date: 2024-12-02 -domain: health -secondary_domains: [] -format: research-paper -status: unprocessed -priority: high -tags: [healthspan, lifespan, disability-adjusted, WHO, global-health, US-exceptionalism, belief-1, noncommunicable-diseases] ---- - -## Content - -Published in *JAMA Network Open*, December 2, 2024. DOI: 10.1001/jamanetworkopen.2024.50241. Mayo Clinic researchers. Examined healthspan-lifespan gaps across 183 WHO member states, 2000–2019. - -**Key findings:** -- Global healthspan-lifespan gap widened from 8.5 years (2000) to 9.6 years (2019) — a 13% increase. -- **The United States has the LARGEST healthspan-lifespan gap in the world: 12.4 years.** -- Other large-gap nations: Australia (12.1 years), New Zealand (11.8 years), UK (11.3 years), Norway (11.2 years). -- Sex disparities: Women's gap is 2.4 years wider than men's on average. -- Gaps positively associated with burden of noncommunicable diseases and total morbidity. -- Companion WHO data: US healthspan actually DECLINED from 65.3 years (2000) to 63.9 years (2021). - -**Context:** This is the JAMA study behind the claim that "Americans live 12.4 years on average with disability and sickness." The US has the largest lifespan-healthspan gap of any developed nation despite having the highest healthcare spending per capita. - -## Agent Notes -**Why this matters:** This is the critical distinction between the 2024 CDC headline (life expectancy record 79 years) and the actual binding constraint. While life expectancy recovered in 2024 (driven by opioid decline + COVID dissipation), healthspan — years lived without disability — DECLINED from 65.3 to 63.9 years. The US has the worst healthy-to-sick ratio among all high-income countries. This directly strengthens Belief 1: the constraint is on *productive, healthy years*, not raw survival. -**What surprised me:** The US has the world's LARGEST healthspan-lifespan gap despite being one of the wealthiest countries. This is not a poverty story — it's a structural healthcare failure that persists even in affluent populations. The wealthiest country produces the least healthy years per life year lived. -**What I expected but didn't find:** Any evidence that the US healthspan-lifespan gap is improving. The trend is widening. -**KB connections:** Core evidence for Belief 1 (healthspan as binding constraint); connects to Belief 3 (structural misalignment — high spending, worst outcomes); links to metabolic disease / food industry claims; relevant to VBC value proposition (preventing disability years, not just deaths). -**Extraction hints:** (1) "US has world's largest healthspan-lifespan gap (12.4 years) despite highest per-capita healthcare spending — structural system failure, not poverty"; (2) "US healthspan declined from 65.3 to 63.9 years (2000-2021) while life expectancy headline improved — lifespan and healthspan are diverging"; (3) "The binding constraint on US productive capacity is not life expectancy but healthy productive years, which are declining." -**Context:** Published December 2024. Cited widely in 2025-2026 longevity discourse. Particularly relevant because the 2024 CDC life expectancy record (January 2026 release) creates a misleading headline that masks the ongoing healthspan deterioration. The two datasets together tell the real story. - -## Curator Notes -PRIMARY CONNECTION: PNAS 2026 cohort paper and Belief 1 grounding claims -WHY ARCHIVED: Provides the healthspan (not life expectancy) dimension of Belief 1; US 12.4-year gap is the most precise evidence that the binding constraint is on productive healthy years -EXTRACTION HINT: The pair of headlines — "US life expectancy record high 79 years" (CDC, Jan 2026) AND "US healthspan 63.9 years and declining" (WHO/JAMA, 2024) — tells the complete story. Extract as a compound claim about lifespan-healthspan divergence. diff --git a/inbox/queue/2025-01-01-jmir-e78132-llm-nursing-care-plan-sociodemographic-bias.md b/inbox/queue/2025-01-01-jmir-e78132-llm-nursing-care-plan-sociodemographic-bias.md deleted file mode 100644 index 1b84763b4..000000000 --- a/inbox/queue/2025-01-01-jmir-e78132-llm-nursing-care-plan-sociodemographic-bias.md +++ /dev/null @@ -1,57 +0,0 @@ ---- -type: source -title: "LLMs Systematically Bias Nursing Care Plan Content AND Expert-Rated Quality Across 96 Sociodemographic Identity Combinations (JMIR, 2025)" -author: "JMIR Research Team (first study of sociodemographic bias in LLM-generated nursing care)" -url: https://www.jmir.org/2025/1/e78132 -date: 2025-01-01 -domain: health -secondary_domains: [ai-alignment] -format: research paper -status: unprocessed -priority: medium -tags: [sociodemographic-bias, nursing-care, llm-clinical-bias, health-equity, gpt, nature-medicine-extension, belief-5, belief-2] ---- - -## Content - -Published in Journal of Medical Internet Research (JMIR), 2025, volume/issue 2025/1, article e78132. Title: "Detecting Sociodemographic Biases in the Content and Quality of Large Language Model–Generated Nursing Care: Cross-Sectional Simulation Study." - -**Study design:** -- Cross-sectional simulation study -- Platform tested: GPT (specific version not specified in summary) -- 96 sociodemographic identity combinations tested -- 9,600 nursing care plans generated and analyzed -- Dual outcome measures: (1) thematic content of care plans, (2) expert-rated clinical quality of care plans -- Described as "first empirical evidence" of sociodemographic bias in LLM-generated nursing care - -**Key findings:** -- LLMs systematically reproduce sociodemographic biases in nursing care plan **content** (what topics/themes are included) -- LLMs systematically reproduce sociodemographic biases in **expert-rated clinical quality** (nurses rating quality differ by patient demographics, holding AI output constant) -- "Reveal a substantial risk that such models may reinforce existing health inequities" - -**Significance:** -- First study of this type specifically for nursing care (vs. physician emergency department decisions in Nature Medicine) -- Bias appears in BOTH the content generated AND the perceived quality — dual pathway -- This extends the Nature Medicine finding (physician emergency department decisions) to a different care setting (nursing care planning), different AI platform (GPT vs. the 9 models in Nature Medicine), and different care type (planned/scheduled vs. emergency triage) - -## Agent Notes - -**Why this matters:** The Nature Medicine 2025 study (9 LLMs, 1.7M outputs, emergency department physician decisions — already archived March 22) showed demographic bias in physician clinical decisions. This JMIR study independently confirms demographic bias in a completely different context: nursing care planning, using a different AI platform, a different research group, and a different care setting. Two independent studies, two care settings, two AI platforms, same finding — pervasive sociodemographic bias in LLM clinical outputs across care contexts and specialties. This strengthens the inference that OE's model (whatever it is) carries similar demographic bias patterns, since the bias has now been documented in multiple contexts. - -**What surprised me:** The bias affects not just content (what topics are covered) but expert-rated clinical quality. This means that clinicians EVALUATING the care plans perceive higher or lower quality based on patient demographics — even when it's the AI generating the content. This is a confound for clinical oversight: if the quality rater is also affected by demographic bias, oversight doesn't catch the bias. - -**What I expected but didn't find:** OE-specific evaluation. This remains absent across all searches. The JMIR study uses GPT; the Nature Medicine study uses 9 models (none named as OE). OE remains unevaluated. - -**KB connections:** -- Extends Nature Medicine (2025) demographic bias finding from physician emergency decisions to nursing care planning — second independent study confirming LLM clinical demographic bias -- Relevant to Belief 2 (non-clinical determinants): health equity implications of AI-amplified disparities connect to SDOH and the structural diagnosis of health inequality -- Relevant to Belief 5 (clinical AI safety): the dual bias (content + quality perception) means that clinical oversight may not catch AI demographic bias because overseers share the same bias patterns - -**Extraction hints:** Primary claim: LLMs systematically produce sociodemographically biased nursing care plans affecting both content and expert-rated clinical quality — the first empirical evidence for this failure mode in nursing. Confidence: proven (9,600 tests, 96 identity combinations, peer-reviewed JMIR). Secondary claim: the JMIR and Nature Medicine findings together establish a pattern of pervasive LLM sociodemographic bias across care settings, specialties, and AI platforms — making it a robust pattern rather than a context-specific artifact. Confidence: likely (two independent studies, different contexts, same directional finding; OE-specific evidence still absent). - -**Context:** JMIR is a high-impact medical informatics journal. The "first empirical evidence" language in the abstract is strong — the authors claim priority for this specific finding (nursing care, dual bias). This will likely generate follow-on work and citations in clinical AI safety discussions. The study's limitation (single AI platform — GPT) is real but doesn't invalidate the finding; it just means replication with other platforms is needed. - -## Curator Notes (structured handoff for extractor) -PRIMARY CONNECTION: Nature Medicine 2025 sociodemographic bias study (already archived) — this JMIR paper is the second independent study confirming the same pattern -WHY ARCHIVED: Extends demographic bias finding to nursing settings — strengthens the inference that OE carries demographic bias by documenting the pattern's robustness across care contexts -EXTRACTION HINT: Extract as an extension of the Nature Medicine finding. The claim should note this is the second independent study confirming LLM sociodemographic bias in clinical contexts. The dual bias (content AND quality) is the novel finding beyond Nature Medicine's scope — make that the distinct claim.